CONTERA PHARMA A/S
33062214ActiveDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Yleiskatsaus
- 19
- Työntekijät
- Tuntematon
- Liikevaihto
- 2010
- Perustettu
Avainpäättäjät
Peter Hagedorn
Scientific Director – Head of Bioinformatics
Maria Wriedt Jakobsen
Clinical Operations Director
Thomas Sager
Chief Executive Officer
Anne Birk Østerskov
Chief Medical Officer
+25 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Contera Pharma is a Danish clinical-stage biotechnology company dedicated to transforming RNA therapeutics for patients with significant unmet medical needs. The organization focuses on developing novel, life-changing treatments for complex neurological disorders by leveraging its proprietary discov...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- A/S
- ALV-numero
- DK33062214
Päättäjät
29 yhteystietoa FunnelfeedrissäPeter Hagedorn
Scientific Director – Head of Bioinformatics
Maria Wriedt Jakobsen
Clinical Operations Director
Thomas Sager
Chief Executive Officer
Anne Birk Østerskov
Chief Medical Officer
Kathrine Baisgaard Bjerno
Chief Financial Officer
Søren Vestergaard Rasmussen
Chief Scientific Officer
Anders Brandt Elvang
Chief Operating Officer & Head of Business Development
Woo-Hyun Lee
Chairman
Mi-Chung Ahn
Board Member
Paul E.G. Kristjansen
Independent Board Member
Dr. Mi-Chung Ahn
Chair of the Board
Dr. Mahmoud Mahmoudian
Independent Board Member
Jeehun Kim
Board Member
Mahmoud Mahmoudian
Independent Board Member
Jae Young Lee
Board Member
Marianne Lerbech Jensen
Lead Scientist – Project Lead
Anca Stoica
Senior Research Scientist – Project Manager R&D Operations
Muut yhteyshenkilöt
Bettina Nordbo
Principal Laboratory Technician
Hjörleifur Einarsson
Bioinformatics Research Scientist
Marijana Oljica
Student Assistant in R&D
Jesper Worm
Principal Scientist
+8 lisää yhteystietoja Funnelfeedrissä
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäNeumirna Therapeutics ApS
9 työntekijätDeveloping miRNA-based therapies to treat complex neurological disease root causes.
ACADIA PHARMACEUTICALS A/S
24 työntekijätA biopharmaceutical company developing innovative therapies for neurological and rare diseases.
Muna Therapeutics ApS
15 työntekijätDeveloping small molecule therapies to treat and stop neurodegenerative diseases.
PTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
ASTELLAS PHARMA A/S
65 työntekijätGlobal pharmaceutical company transforming innovative science into value for patients.
Selaa lisää
Kysymyksiä yrityksestä CONTERA PHARMA A/S
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo